Systems and methods for generating germicidal compositions

ABSTRACT

The present invention relates to systems and methods for generating germicidal compositions for use in a wide variety of settings, including agricultural settings, food production settings, hospitality settings, health care settings, health club settings, exercise facility settings, research based settings, veterinarian settings, medical settings, hydraulic fracturing settings, and/or any setting requiring disinfection.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of pending U.S. patentapplication Ser. No. 13/621,645, filed Sep. 17, 2012, which claimspriority to expired U.S. Provisional Patent Application No. 61/535,829,filed Sep. 16, 2011 and which claims priority to expired U.S.Provisional Patent Application No. 61/598,153, filed Feb. 13, 2012, thecontents of which are incorporated by reference in their entireties.

FIELD OF THE INVENTION

The present invention relates to systems and methods for generatinggermicidal compositions for use in a wide variety of settings, includingagricultural settings, food production settings, hospitality settings,health care settings, health club settings, exercise facility settings,research based settings, veterinarian settings, medical settings,hydraulic fracturing settings, and/or any setting requiringdisinfection.

BACKGROUND

Today's consumer demands that the product they are provided be of thehighest quality and safe to eat or drink. The production and processingof safe, nutritional, high quality milk and food starts on the farm. Asfarms get larger their ability to defend and control their operationsagainst pest and harmful micro-organisms becomes even more critical.Pure water, animal and premise hygiene are indispensable in awell-managed operation (e.g., agricultural setting).

Improved and more comprehensive on-farm hygiene tools leading to a safeand wholesome agriculturally-based products (e.g., milk and foodproducts) and healthy animals for the generation of such products areneeded.

SUMMARY OF THE INVENTION

The present invention relates to systems and methods for generatinggermicidal compositions for use in a wide variety of settings, includingagricultural settings, food production settings, hospitality settings,health care settings, health club settings, exercise facility settings,research based settings, veterinarian settings, medical settings,hydraulic fracturing settings, and/or any setting requiringdisinfection.

The systems and methods of the present invention provide new levels ofhygiene protection, providing solutions created on-site, with superiorgermicidal efficacy at a fraction of the cost of current germicidalalternatives. For example, the systems and methods of the presentinvention provide the ability to create a concentrated germicidalsolution, to be used in a multitude of on-farm applications, at afraction of the cost of common disinfectants. Moreover, the presentinvention provides compositions configured for specific disinfectantpurposes.

Accordingly, in certain embodiments, the present invention providessystems comprising a sodium chloride solution, water, an electrolyticcell, and at least one chamber wherein the electrolytic cell isconfigured to a) receive the sodium chloride solution mixed with thewater, b) remove hydrogen from the sodium chloride solution mixed withthe water, and c) generate a germicidal composition and wherein thechamber is configured to receive the germicidal composition generatedwith the electrolytic cell.

The systems are not limited to a particular manner of generating thegermicidal composition. In some embodiments, the germicidal compositionis generated through removal of hydrogen from the sodium chloridesolution mixed with the water. In some embodiments, the electrolyticcell is configured to generate the germicidal composition comprising acombination of chlorine, hypochlorite, hypochlorous acid and chlorinedioxide.

In some embodiments, the germicidal composition is measured in parts permillion (PPM) of free available chlorine (FAC). The combination ofchlorines (e.g., a combination of chlorine, hypochlorite, hypochlorousacid and chlorine dioxide) has been proven to be many times moreeffective than common chlorine bleach (sodium hypochlorite), and is safewhen applied on skin tissue. In some embodiments, the PPM of FAC in agermicidal composition can be modified to meet the needs of a wide rangeof dairy sizes and desired uses/needs. In some embodiments, the systemand methods of the present invention are capable of generatinggermicidal composition at any desired amount and/or concentration (e.g.,in an amount from 125,000 PPM of FAC up to 25,000,000 PPM of FAC withina 24 hour production period) (e.g., in a range from 1,440,000 PPM of FAC(e.g., 180 gallons of 8,000 PPM of FAC) up to 4,800,000 PPM of FACwithin a 24 hour production period)).

The systems of the present invention are not limited to use within aparticular setting. Indeed, in some embodiments, the systems may be usedin facility settings (e.g., external sanitation; flooring sanitation;equipment sanitation; vehicle sanitation; etc.), food settings (e.g.,food preparation settings; animal eating settings; storage of foodsettings), water treatment settings, and/or animal hygiene settings.

In some embodiments, the system further comprises two or more additionalagents, wherein the two or more additional agents are stored in a mannerpermitting combination of a generated germicidal composition with anycombination (e.g., via blending/mixing) of two or more of the additionalagents.

The present invention is not limited to a particular manner ofcombination of the germicidal composition and the two or more additionalagents. In some embodiments, the combination is configured to occurautomatically. In some embodiments, the system is configured to provideany programmed amount of the two or more additional agents for purposesof combination.

The present invention is not limited to particular additional agents.Examples of an additional agent includes, but is not limited to, water,a detergent polymer (e.g., Acusol), a surfactant (e.g., tomadolethoxylate) (e.g, an ionic surfactant) (e.g., a non-ionic surfactant)(e.g., a cationic quarternary ammonion compound (e.g., cetylpyridiniumchloride (e.g., Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride(e.g., BTC-835)) (e.g., an amphoteric surfactant (e.g., KDC-3) (e.g.,amphoteric LH)), a hydrotope (e.g., sodium xylene sulfonate), a dye(e.g., tartrazine (dye keyacid tart yellow)) (e.g., blue dye) (e.g.,green grams), citric acid, an emollient (e.g., propylene glycol) (e.g.,urea), a sequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), an odorant (e.g., perfume), a mineral acid (e.g., VidetA-85), and a medicinal agent for animal hygiene, facility hygiene,general sanitization, disinfection and water treatment preparationpurposes.

In some embodiments, the system generates a combination of a germicidalcomposition and water, a detergent polymer (e.g., Acusol), a surfactant(e.g., tomadol ethoxylate) (e.g, an ionic surfactant) (e.g., a non-ionicsurfactant) (e.g., a cationic quarternary ammonion compound (e.g.,cetylpyridinium chloride (e.g., Ammonyx)) (e.g., alkyl dimethylbenzylammonium chloride (e.g., BTC-835)) (e.g., an amphoteric surfactant(e.g., KDC-3) (e.g., amphoteric LH)), a hydrotope (e.g., sodium xylenesulfonate), and a dye (e.g., tartrazine (dye keyacid tart yellow))(e.g., blue dye) (e.g., green grams). In some embodiments, such acombination is configured for pre-milking udder preparation purposes.

In some embodiments, the system generates a combination of a germicidalcomposition and water, a detergent polymer (e.g., Acusol), citric acid,a surfactant (e.g., tomadol ethoxylate) (e.g, an ionic surfactant)(e.g., a non-ionic surfactant) (e.g., a cationic quarternary ammonioncompound (e.g., cetylpyridinium chloride (e.g., Ammonyx)) (e.g., alkyldimethyl benzylammonium chloride (e.g., BTC-835)) (e.g., an amphotericsurfactant (e.g., KDC-3) (e.g., amphoteric LH)), an emollient (e.g.,propylene glycol) (e.g., urea), a sequestration agent (e.g., chelatingagent (e.g., versene 100/sequestrene 30A)) (e.g., potassium hydroxide(e.g., caustic potash)) (e.g., sodium hydroxide (e.g., caustic soda))(e.g., magnesium hydroxide (e.g., flogel)), and a dye (e.g., tartrazine(dye keyacid tart yellow)) (e.g., blue dye) (e.g., green grams). In someembodiments, such a combination is configured for post-milking teatpurposes.

The present invention further provides post-milking teat solutionshaving a noticeable color when applied to a tissue (e.g., a teat) (e.g.,blue, red, yellow, black, orange). In some embodiments, the color isconfigured to remain noticeable when applied to a tissue for an extendedperiod of time (e.g., 1 minute, 10 minutes, 20 minutes, 1 hour, 6 hours,12 hours, 1 day, etc.).

In some embodiments, the system generates a combination of a germicidalcomposition and water, a surfactant (e.g., tomadol ethoxylate) (e.g, anionic surfactant) (e.g., a non-ionic surfactant) (e.g., a cationicquarternary ammonion compound (e.g., cetylpyridinium chloride (e.g.,Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride (e.g., BTC-835))(e.g., an amphoteric surfactant (e.g., KDC-3) (e.g., amphoteric LH)), asequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), an odorant (e.g., perfume), and a dye (e.g., tartrazine(dye keyacid tart yellow)) (e.g., blue dye) (e.g., green grams). In someembodiments, such a combination is configured for laundry purposes.

In some embodiments, the system generates a combination of a germicidalcomposition and water, a sequestration agent (e.g., chelating agent(e.g., versene 100/sequestrene 30A)) (e.g., potassium hydroxide (e.g.,caustic potash)) (e.g., sodium hydroxide (e.g., caustic soda)) (e.g.,magnesium hydroxide (e.g., flogel)), and a detergent polymer (e.g.,Acusol). In some embodiments, such a combination is configured forcleaning-in-place purposes.

In some embodiments, the system generates a combination of a germicidalcomposition and water, a detergent polymer (e.g., Acusol), asequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), a hydrotope (e.g., sodium xylene sulfonate), asurfactant (e.g., tomadol ethoxylate) (e.g, an ionic surfactant) (e.g.,a non-ionic surfactant) (e.g., a cationic quarternary ammonion compound(e.g., cetylpyridinium chloride (e.g., Ammonyx)) (e.g., alkyl dimethylbenzylammonium chloride (e.g., BTC-835)) (e.g., an amphoteric surfactant(e.g., KDC-3) (e.g., amphoteric LH)). In some embodiments, such acombination is configured for premise purposes.

In some embodiments, the system generates a combination of a germicidalcomposition and water, a surfactant (e.g., tomadol ethoxylate) (e.g, anionic surfactant) (e.g., a non-ionic surfactant) (e.g., a cationicquarternary ammonion compound (e.g., cetylpyridinium chloride (e.g.,Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride (e.g., BTC-835))(e.g., an amphoteric surfactant (e.g., KDC-3) (e.g., amphoteric LH)),and a mineral acid (e.g., Videt A-85). In some embodiments, such acombination is configured for footbath purposes.

In some embodiments, the system generates a germicidal compositionconfigured for use in hydraulic fracturing settings. The system is notlimited to a particular hydraulic fracturing setting. In someembodiments, the hydraulic fracturing setting involves extraction ofoil. In some embodiments, the hydraulic fracturing setting involvesextraction of natural gas. The germicidal compositions are not limitedto a particular use within a hydraulic fracturing setting. In someembodiments, the germicidal composition is used to inhibit and/or killthe growth of bacteria and/or microorganisms associated within ahydraulic fracturing setting. In some embodiments, the germicidalcompositions are configured to prevent the bacteria and/ormicroorganisms from producing contaminate byproducts (e.g., gas). Insome embodiments, the germicidal compositions are configured to preventthe bacteria and/or microorganisms from interfering with (e.g., breakingdown) agents used in hydraulic fracturing (e.g., gelling agents) (e.g.,fracturing fluid). In some embodiments, the germicidal compositions usedto inhibit and/or kill the growth of bacteria and/or microorganismsassociated within a hydraulic fracturing setting is combined with one ormore additional agents. Examples of additional agents include, but arenot limited to, water, a detergent polymer (e.g., Acusol), a surfactant(e.g., tomadol ethoxylate), cetylpyridinium chloride (e.g., Ammonyx),sodium xylene sulfonate, an amphoteric surfactant (e.g., KDC-3), asurfactant (e.g., tomadol ethoxylate) (e.g, an ionic surfactant) (e.g.,a non-ionic surfactant) (e.g., a cationic quarternary ammonion compound(e.g., cetylpyridinium chloride (e.g., Ammonyx)) (e.g., alkyl dimethylbenzylammonium chloride (e.g., BTC-835)) (e.g., an amphoteric surfactant(e.g., KDC-3) (e.g., amphoteric LH)), a dye (e.g., tartrazine (dyekeyacid tart yellow)), citric acid, an emollient (e.g., propyleneglycol) (e.g., urea), blue dye, a sequestration agent (e.g., chelatingagent (e.g., versene 100/sequestrene 30A)) (e.g., potassium hydroxide(e.g., caustic potash)) (e.g., sodium hydroxide (e.g., caustic soda))(e.g., magnesium hydroxide (e.g., flogel)), an odorant (e.g., perfume),a dye (e.g., green grams), alkyl dimethyl benzylammonium chloride (e.g.,BTC-835), a mineral acid (e.g., Videt A-85), and a medicinal agent. Insome embodiments, the germicidal composition is co-administered with anadditional bactericide and/or biocide (e.g.,2,2-Dibromo-3-nitrilopropionamide, polynuclear aromatic hydrocarbons,polycyclic organic matter, gluteraldehyde).

In some embodiments, the system is a closed system (e.g., formaintaining a sterile setting) (e.g., for maintaining a controlledsetting).

In some embodiments, the systems further comprise a processor running analgorithm. In some embodiments, the algorithm is configured regulate thegeneration of the germicidal composition. In some embodiments, thealgorithm is configured to regulate the combination of the germicidalcomposition with the two or more additional agents. In some embodiments,the algorithm is configured to present alerts regarding the system.Examples of such alerts include, but are not limited to, germicidalcomposition amount levels, time periods, identifications of usedadditional agents, system malfunctions, additional agent amount levels,sterility contaminations, amount levels of the germicidal compositioncombined with the additional agents.

In certain embodiments, the present invention provides methods forgenerating compositions comprising germicidal compositions combined withadditional agents with such a system.

In certain embodiments, the present invention provides compositionsgenerated with such systems and/or methods.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts a process involving Electro-Chemical Activation, whichinvolves the process of passing a sodium chloride solution, and treatedwater (1) through an electrolytic cell (2) in order to generate, byelectro-chemical energy conversion, a germicidally active solution (3).

FIG. 2 shows a system for generating ECAcept Concentrate (see, e.g.,Brine Tank and Process Tank), and combining it with additional agents(see, e.g., Additive 1A, Additive 2A, and Additive 3A) via the mixingstation to create modified EACcept Concentrate (see, e.g., 1B, 2B, 3B).

DETAILED DESCRIPTION

The systems and methods of the present invention are not limited to useand/or application within a particular setting. In some embodiments, thesystems and methods of the present invention are used within ananimal-based setting (e.g., agricultural, veterinarian, academic,research based, etc). In some embodiments, the systems and methods ofthe present invention are used within a hydraulic fracturing setting. Insome embodiments, the systems and methods of the present invention areused within any setting requiring use and/or application of adisinfectant.

In particular, the present invention utilizes Electro-ChemicalActivation (ECA). The present invention is not limited to particulartechnique or mechanism associated with ECA. In some embodiments, ECAinvolves the process of passing a sodium chloride solution, and treatedwater (1) through an electrolytic cell (2) in order to generate, byelectro-chemical energy conversion, a germicidally active solution (3)(see, e.g., FIG. 1). Accordingly, the present invention providesdevices, systems and methods utilizing ECA.

The present invention are not limited to a particular sodium chloridesolution. In some embodiments, the sodium chloride solution is ECAceptActivator solution. The present invention is not limited to a particularECAcept Activator solution. In some embodiments, the ECAcept Activatorsolution comprises an aqueous, purified sodium chloride solution. Insome embodiments, the sodium chloride solution is a brine solution. Thepresent invention is not limited to particular concentration and/orpurification parameters for the sodium chloride solution.

The present invention is not limited to a particular electrolytic cell.In some embodiments, the electrolytic cell is configured to efficientlyand reliably generate chlorine from a base solution (e.g., a basesolution comprising a sodium chloride solution). In some embodiments,the electrolytic cell is configured to liberate hydrogen from a basesolution (e.g., a base solution comprising a sodium chloride solution).In some embodiments, the electrolytic cell is configured for passiveand/or active hydrogen removal. In some embodiments, the electrolyticcell is configured for high velocity electrolyte flow, sodium chloridesolution conductivity control, full wave D.C. rectification,recirculating cell loop, and/or no cell electrode penetrations. In someembodiments, the electrolytic cell is configured to generate a solutioncomprising chlorine, hypochlorite, hypochlorous acid and chlorinedioxide from a sodium chloride solution. In some embodiments, theelectrolytic cell is as described or similar to the electrolytic cellsdescribed in U.S. Pat. No. 7,897,022, U.S. patent application Ser. Nos.13/026,947 and 13/026,939; each of which are herein incorporated byreference in their entireties.

The present invention is not limited to a particular germicidally activesolution. In some embodiments, the germicidally active solution isECAcept Concentrate. The systems and methods of the present inventionare not limited to a particular ECAcept Concentrate. In someembodiments, the ECAcept Concentrate solution is, for example, acombination of chlorine, hypochlorite, hypochlorous acid and chlorinedioxide.

Accordingly, the present invention provides compositions comprisingECAcept Concentrate. The ECAcept Concentrate is not limited toparticular measurement and/or concentration parameters. In someembodiments, the ECAcept Concentrate is measured in parts per million(PPM) of free available chlorine (FAC). The combination of chlorines hasbeen proven to be many times more effective than common chlorine bleach(sodium hypochlorite), and is safe when applied on skin tissue. In someembodiments, the PPM of FAC in a ECAcept Concentrate can be modified tomeet the needs of a wide range of dairy sizes and desired uses/needs. Insome embodiments, the system and methods of the present invention arecapable of generating ECAcept Concentrate at any desired amount and/orconcentration (e.g., in an amount from 125,000 PPM of FAC up to25,000,000 PPM of FAC within a 24 hour production period) (e.g., in arange from 1,440,000 PPM of FAC (e.g., 180 gallons of 8,000 PPM of FAC)up to 4,800,000 PPM of FAC within a 24 hour production period).

The ECAcept Concentrate is not limited to a particular use or function.In some embodiments, the ECAcept Concentrate is a powerful disinfectant.Indeed, experiments conducted during the course of developingembodiments for the present invention demonstrated that generatedECAcept Concentrate is 10 times more efficient at the same dilution rateat killing harmful micro-organisms than standard commercial bleach(e.g., 5.25%-12.5% sodium hypochlorite), without having caustic,corrosive, skin harming characteristics. The ECAcept Concentrate is notlimited to particular disinfectant uses. In some embodiments, theECAcept Concentrate is used for animal hygiene disinfectant purposes.For example, in some embodiments, the ECAcept Concentrate is used forpre and/or post milking hygiene purposes. For example, in someembodiments, the ECAcept Concentrate is used for hoof treatment. In someembodiments, the ECAcept Concentrate is used for premise hygienepurposes. For example, in some embodiments, the ECAcept Concentrate isused for cleaning, disinfecting, and/or sanitizing the structuralpremise (e.g., the exterior walls, platforms, etc). In some embodiments,the ECAcept Concentrate is used for equipment cleaning, disinfecting,and/or sanitizing. In some embodiments, the ECAcept Concentrate is usedfor cleaning, disinfecting, and/or sanitizing the calf hutches,treatment, and/or hospital areas. In some embodiments, the ECAceptConcentrate is used for cleaning, disinfecting, and/or sanitizing thecleaning-in-place (CIP) locations. In some embodiments, the ECAceptConcentrate is used for cleaning, disinfecting, and/or sanitizing thelaundry locations. In some embodiments, the ECAcept Concentrate is usedfor water treatment. For example, in some embodiments, the ECAceptConcentrate is used for iron and/or manganese remediation from a watersource. In some embodiments, the ECAcept Concentrate is used for biofilmremoval from a water source. In some embodiments, the ECAceptConcentrate is used for disinfecting a water source. In someembodiments, the ECAcept Concentrate is generated with a relativelyneutral pH so as to keep the solution safe for skin contact (e.g.,contact with cow teats and skin tissue).

In some embodiments, following its generation, the ECAcept Concentrateis further modified for enhanced purposes and/or uses. The presentinvention is not limited to a particular manner of modifying the ECAceptConcentrate. In some embodiments, the ECAcept Concentrate is furthermodified through combination with additional agents.

For example, in some embodiments, pre-milking udder preparationsolutions are generated by combining the ECAcept Concentrate withadditional agents. The present invention is not limited to particularagents. In some embodiments, a pre-milking udder preparation solution isgenerated by combining the ECAcept Concentrate with, for example, one ormore of water, a detergent polymer (e.g., Acusol), a surfactant (e.g.,tomadol ethoxylate) (e.g, an ionic surfactant) (e.g., a non-ionicsurfactant) (e.g., a cationic quarternary ammonion compound (e.g.,cetylpyridinium chloride (e.g., Ammonyx)) (e.g., alkyl dimethylbenzylammonium chloride (e.g., BTC-835)), (e.g., an amphotericsurfactant (e.g., KDC-3) (e.g., amphoteric LH)), a hydrotope (e.g.,sodium xylene sulfonate), and a dye (e.g., tartrazine (dye keyacid tartyellow)) (e.g., blue dye) (e.g., green grams). In some embodiments, thepre-milking udder preparation solution further comprises an emollient(e.g., propylene glycol) (e.g., urea). The pre-milking udder preparationsolutions are not limited to particular ingredient parameters (e.g.,amounts relative to other ingredients, concentrations, pH levels,dilution amounts, etc.).

In some embodiments, post-milking teat solutions are generated bycombining the ECAcept Concentrate with additional agents. The presentinvention is not limited to particular agents. In some embodiments, thepost-milking teat solution is generated by combining the ECAceptConcentrate with, for example, one or more of water, a detergent polymer(e.g., Acusol), citric acid, a surfactant (e.g., tomadol ethoxylate)(e.g, an ionic surfactant) (e.g., a non-ionic surfactant) (e.g., acationic quarternary ammonion compound (e.g., cetylpyridinium chloride(e.g., Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride (e.g.,BTC-835)) (e.g., an amphoteric surfactant (e.g., KDC-3) (e.g.,amphoteric LH)), an emollient (e.g., propylene glycol) (e.g., urea), asequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), and a dye (e.g., tartrazine (dye keyacid tart yellow))(e.g., blue dye) (e.g., green grams). In some embodiments, thepost-milking teat solution further comprises a polyvinyl alcohol (e.g.,celvol 205-S). The post-milking teat solutions are not limited toparticular ingredient parameters (e.g., amounts relative to otheringredients, concentrations, pH levels, dilution amounts, etc.).

In some embodiments, laundry solutions are generated by combining theECAcept Concentrate with additional agents. The present invention is notlimited to particular agents. In some embodiments, the laundry solutionsare generated by combining the ECAcept Concentrate with, for example,one or more of water, a surfactant (e.g., tomadol ethoxylate) (e.g, anionic surfactant) (e.g., a non-ionic surfactant) (e.g., a cationicquarternary ammonion compound (e.g., cetylpyridinium chloride (e.g.,Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride (e.g., BTC-835))(e.g., an amphoteric surfactant (e.g., KDC-3) (e.g., amphoteric LH)), asequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), an odorant (e.g., perfume), and a dye (e.g., tartrazine(dye keyacid tart yellow)) (e.g., blue dye) (e.g., green grams). Thelaundry solutions are not limited to particular ingredient parameters(e.g., amounts relative to other ingredients, concentrations, pH levels,dilution amounts, etc.).

In some embodiments, cleaning-in-place (CIP) solutions are generated bycombining the ECAcept Concentrate with additional agents. The presentinvention is not limited to particular agents. In some embodiments, thecleaning-in-place solutions are generated by combining the ECAceptConcentrate with, for example, one or more of water, a sequestrationagent (e.g., chelating agent (e.g., versene 100/sequestrene 30A)) (e.g.,potassium hydroxide (e.g., caustic potash)) (e.g., sodium hydroxide(e.g., caustic soda)) (e.g., magnesium hydroxide (e.g., flogel)), and adetergent polymer (e.g., Acusol). The cleaning-in-place solutions arenot limited to particular ingredient parameters (e.g., amounts relativeto other ingredients, concentrations, pH levels, dilution amounts,etc.).

In some embodiments, premise solutions are generated by combining theECAcept Concentrate with additional agents. The present invention is notlimited to particular agents. In some embodiments, the premise solutionsare generated by combining the ECAcept Concentrate with, for example,one or more of water, a detergent polymer (e.g., Acusol), asequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), a hydrotope (e.g., sodium xylene sulfonate), asurfactant (e.g., tomadol ethoxylate) (e.g, an ionic surfactant) (e.g.,a non-ionic surfactant) (e.g., a cationic quarternary ammonion compound(e.g., cetylpyridinium chloride (e.g., Ammonyx)) (e.g., alkyl dimethylbenzylammonium chloride (e.g., BTC-835)) (e.g., an amphoteric surfactant(e.g., KDC-3) (e.g., amphoteric LH)). The premise solutions are notlimited to particular ingredient parameters (e.g., amounts relative toother ingredients, concentrations, pH levels, dilution amounts, etc.).

In some embodiments, footbath solutions are generated by combining theECAcept Concentrate with additional agents. The present invention is notlimited to particular agents. In some embodiments, the footbathsolutions are generated by combining the ECAcept Concentrate with, forexample, one or more of water, a surfactant (e.g., tomadol ethoxylate)(e.g, an ionic surfatant) (e.g., a non-ionic surfactant) (e.g., acationic quarternary ammonion compound (e.g., cetylpyridinium chloride(e.g., Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride (e.g.,BTC-835)) (e.g., an amphoteric surfactant (e.g., KDC-3) (e.g.,amphoteric LH)), and a mineral acid (e.g., Videt A-85). The footbathsolutions are not limited to particular ingredient parameters (e.g.,amounts relative to other ingredients, concentrations, pH levels,dilution amounts, etc.).

In some embodiments, medicinal solutions are generated by combining theECAcept Concentrate with additional agents. In some embodiments, themedicinal solutions are configured for topical application. In someembodiments, the medicinal solutions are configured for oraladministration. In some embodiments, the medicinal solutions areconfigured for intravenous administration. The present invention is notlimited to particular agents. In some embodiments, the medicinalsolutions are generated by combining the ECAcept Concentrate with, forexample, one or more agents designed to prevent and/or treat a medicalcondition (e.g., anti-biotic agents, anti-microbial agents, sedatingagents, analgesic agents, specific medical condition treatment agents(e.g., agents designed to treat and/or prevent mastitis) (e.g., agentsdesigned to treat and/or prevent conditions associated with mucosal andnon-mucosal tissue) (e.g., agents designed to treat and/or prevent pinkeye, tissue rash) (e.g., agents designed to treat and/or preventconditions associated with wounds), growth inducing agents (e.g.,hormones), vitamins, etc.).

The present invention is not limited to a particular technique forcombining the ECAcept Concentrate with additional agents. In someembodiments, the additional agents are stored within a system/devicethat generates the ECAcept Concentrate. For example, FIG. 2 shows asystem for generating ECAcept Concentrate (see, e.g., Brine Tank andProcess Tank), and combining it with additional agents (see, e.g.,Additive 1A, Additive 2A, and Additive 3A) via the mixing station tocreate modified EACcept Concentrate (see, e.g., 1B, 2B, 3B) (e.g., apre-milking udder preparation solution; a post-milking teat solution; alaundry solution; a cleaning-in-place solution; a premise solution; afootbath solution). In some embodiments, the additional agents arestored within a system/device that generates the ECAcept Concentrate ina manner that permits combination with generated ECAcept Concentrate ina closed setting (e.g., thereby maintaining a controlled and/or asterile setting) (e.g., the system shown in FIG. 2). In someembodiments, the additional agents are stored in a manner compatiblewith RFID technology (e.g., the additional agent container if flaggedwith an RFID tag) and the system is has RFID tags. In some suchembodiments, the systems are configured to operate only if the RFID tagsmatch in a desired manner (e.g., additional agents stored in a mannernot having RFID tag matching with the system RFID tag results innon-system operation). In some embodiments, the system is configuredsuch that generation of ECAcept Concentrate and combination withadditional agents occurs within the same setting (e.g., the samelocation). In some embodiments, the system is configured such thatgeneration of ECAcept Concentrate and combination with additional agentsoccurs at different locations. In some embodiments, generation of amodified ECAcept Concentrate (e.g., a pre-milking udder preparationsolution; a post-milking teat solution; a laundry solution; acleaning-in-place solution; a premise solution; a footbath solution) iscontrolled by a user prior to generation of ECAcept Concentrate. In someembodiments, generation of a modified ECAcept Concentrate (e.g., apre-milking udder preparation solution; a post-milking teat solution; alaundry solution; a cleaning-in-place solution; a premise solution; afootbath solution) is controlled by a user following generation ofECAcept Concentrate. In some embodiments, generation of a modifiedECAcept Concentrate is physically accomplished by a user. In someembodiments, generation of a modified ECAcept Concentrate is occursautomatically (e.g., user-free).

The present invention provides systems configured to generate ECAceptConcentrate and/or modified ECAcept Concentrate (e.g., a pre-milkingudder preparation solution; a post-milking teat solution; a laundrysolution; a cleaning-in-place solution; a premise solution; a footbathsolution). In some embodiments, the system comprises a sodium chloridesolution, water, an electrolytic cell, and chamber forcollecting/storing generated ECAcept Concentrate. In some embodiments,the system comprises a sodium chloride solution, water, an electrolyticcell, additional agents for generating modified ECAcept Concentrate, andchamber for collecting/storing generated ECAcept Concentrate and/ormodified ECAcept Concentrate. In some embodiments, all aspects of thesystem are controllable by a user. For example, the amount of ECAceptConcentrate and/or modified ECAcept Concentrate (e.g., over a period oftime) may be controlled, the particular concentrations (e.g., PPM ofFAC) may be controlled. In addition, the amount of additional agents touse when generating modified ECAcept Concentrate (e.g., a pre-milkingudder preparation solution; a post-milking teat solution; a laundrysolution; a cleaning-in-place solution; a premise solution; a footbathsolution) may be controlled so as to generate a precisely desired endproduct. In addition, in some embodiments, the system has a processor(e.g., a computer interface) (e.g., an algorithm) for facilitating suchcontrol. In some embodiments, the processor is compatible with html5 orhigher format. In some embodiments, the system may be controlled eitheron-site or off-site (e.g., via wireless (e.g., wi-fi) interaction). Insome embodiments, the system may be controlled via an application (e.g.,a downloadable phone application). In some embodiments, the system isconfigured to present data to a user (e.g., concentration levels ofparticular ECAcept Concentrate solutions and/or modified ECAceptConcentrate solutions) (e.g., amounts of particular ECAcept Concentratesolutions and/or modified ECAcept Concentrate solutions) (e.g., warningsas to particular ECAcept Concentrate solutions and/or modified ECAceptConcentrate solutions (e.g., warnings that amounts are too high or low))(e.g., sterility contaminations). In some embodiments, the systems maybe programmable to automatically generate desired ECAcept Concentrateand/or modified ECAcept Concentrate solutions (e.g., programmed toautomatically generate more solution upon the occurrence of certainevents (e.g., stored amounts reaching particular levels, elapsing of aparticular time-span, etc.)). In some embodiments, the systems areconfigured to monitor the generation of ECAcept Concentrate and/ormodified ECAcept concentrate to ensure proper generation according toprogrammed parameters and/or to ensure quality control. The systems arefurther configured to store generated ECAcept Concentrate and/ormodified ECAcept Concentrate in a controlled and/or sterile manner, inany desired amount, for any extended amount of time. The systems arefurther configured to store generated ECAcept Concentrate and/ormodified ECAcept Concentrate in a tightly controlled manner, in anydesired amount, for any extended amount of time. The systems are furtherconfigured to store multiple solutions of ECAcept Concentrate, modifiedECAcept Concentrate, and/or additional agents at any given time. Thesystems are further configured to dispense generated ECAcept Concentrateand/or modified ECAcept Concentrate in a controlled and/or sterilemanner, in any desired amount, for any extended amount of time. Thesystems are further configured to dispense generated ECAcept Concentrateand/or modified ECAcept Concentrate in a tightly controlled manner, inany desired amount, for any extended amount of time. The presentinvention provides methods for generating ECAcept Concentrate and/ormodified ECAcept Concentrate (e.g., a pre-milking udder preparationsolution; a post-milking teat solution; a laundry solution; acleaning-in-place solution; a premise solution; a footbath solution)with such a system.

In some embodiments, the system generates a germicidal compositionconfigured for use in hydraulic fracturing settings. The system is notlimited to a particular hydraulic fracturing setting. In someembodiments, the hydraulic fracturing setting involves extraction ofoil. In some embodiments, the hydraulic fracturing setting involvesextraction of natural gas. Hydraulic fracturing is used to, for example,increase or restore the rate at which fluids, such as petroleum, water,or natural gas can be produced from subterranean natural reservoirs.Reservoirs are typically, for example, porous sandstones, limestones ordolomite rocks, but also include ‘unconventional reservoirs’ such asshale rock or coal beds. Hydraulic fracturing enables the production ofnatural gas and oil from rock formations deep below the earth's surface(generally 5,000-20,000 feet (1,500-6,100 m)). At such depth, there maynot be sufficient permeability or reservoir pressure to allow naturalgas and oil to flow from the rock into the wellbore at economic rates.Thus, creating conductive fractures in the rock is essential to extractgas from shale reservoirs because of the extremely low naturalpermeability of shale. Fractures provide a conductive path connecting alarger area of the reservoir to the well, thereby increasing the areafrom which natural gas and liquids can be recovered from the targetedformation.

Problems associated with efficient hydraulic fracturing yields include,for example, bacteria and microorganisms that produce contaminant gas,break down gelling agents, and reduce the viscosity of fracturing fluid.In order to overcome such problems, the present invention providesgermicidal compositions used to inhibit and/or kill the growth ofbacteria and/or microorganisms associated within a hydraulic fracturingsetting. In some embodiments, the germicidal compositions are configuredto prevent the bacteria and/or microorganisms from producing contaminatebyproducts (e.g., gas). In some embodiments, the germicidal compositionsare configured to prevent the bacteria and/or microorganisms frominterfering with (e.g., breaking down) agents used in hydraulicfracturing (e.g., gelling agents) (e.g., fracturing fluid). In someembodiments, the germicidal compositions used to inhibit and/or kill thegrowth of bacteria and/or microorganisms associated within a hydraulicfracturing setting is combined with one or more additional agents.Examples of additional agents include, but are not limited to, water, adetergent polymer (e.g., Acusol), a surfactant (e.g., tomadolethoxylate) (e.g, an ionic surfactant) (e.g., a non-ionic surfactant)(e.g., a cationic quarternary ammonion compound (e.g., cetylpyridiniumchloride (e.g., Ammonyx)) (e.g., alkyl dimethyl benzylammonium chloride(e.g., BTC-835)) (e.g., an amphoteric surfactant (e.g., KDC-3) (e.g.,amphoteric LH)), cetylpyridinium chloride (e.g., Ammonyx), sodium xylenesulfonate, a dye (e.g., tartrazine (dye keyacid tart yellow)), citricacid, an emollient (e.g., propylene glycol) (e.g., urea), blue dye, asequestration agent (e.g., chelating agent (e.g., versene100/sequestrene 30A)) (e.g., potassium hydroxide (e.g., caustic potash))(e.g., sodium hydroxide (e.g., caustic soda)) (e.g., magnesium hydroxide(e.g., flogel)), an odorant (e.g., perfume), a dye (e.g., green grams),sodium xylene sulfonate, alkyl dimethyl benzylammonium chloride (e.g.,BTC-835), a mineral acid (e.g., Videt A-85), and a medicinal agent. Insome embodiments, the germicidal composition is co-administered with anadditional bactericide and/or biocide (e.g.,2,2-Dibromo-3-nitrilopropionamide, polynuclear aromatic hydrocarbons,polycyclic organic matter, gluteraldehyde).

INCORPORATION BY REFERENCE

The entire disclosure of each of the patent documents and scientificarticles referred to herein is incorporated by reference for allpurposes.

EQUIVALENTS

The invention may be embodied in other specific forms without departingfrom the spirit or essential characteristics thereof. The foregoingembodiments are therefore to be considered in all respects illustrativerather than limiting the invention described herein. Scope of theinvention is thus indicated by the appended claims rather than by theforegoing description, and all changes that come within the meaning andrange of equivalency of the claims are intended to be embraced therein.

1. (canceled)
 2. A method for on-site production of a germicidalcomposition, comprising generating a concentrate through passing asodium chloride solution through an electrolytic cell such that hydrogenis removed from the sodium chloride solution, and producing a germicidalcomposition through automatically combining one or more additionalagents with the generated concentrate, wherein the one or moreadditional agents are selected from the group consisting of a detergentpolymer, a surfactant, a hydrotrope, a dye, citric acid, an emollient, asequestration agent, an odorant, a mineral acid, a medicinal agent, andwater.
 3. The method of claim 2, wherein the step of generating thegermicidal composition occurs in a chamber separate from theelectrolytic cell.
 4. The method of claim 2, wherein the steps ofgenerating the concentrate and producing the germicidal compositionoccur in a closed setting.
 5. The method of claim 4, wherein thegermicidal composition is removed from the closed setting followingproduction.
 6. The method of claim 2, wherein the germicidal compositionis sterile.
 7. The method of claim 2, wherein the one or more additionalagents are a detergent polymer, a surfactant, a hydrotope, water and adye.
 8. The method of claim 7, wherein germicidal composition is forpre-milking udder preparation cleaning.
 9. The method of claim 2,wherein the one or more additional agents are a detergent polymer,citric acid, a surfactant, an emollient, a sequestration agent, waterand a dye.
 10. The method of claim 9, wherein the germicidal compositionis for post-milking teat cleaning.
 11. The method of claim 2, whereinthe one or more additional agents are a surfactant, a sequestrationagent, an odorant, water and a dye.
 12. The method of claim 11, whereingermicidal composition is for laundry cleaning.
 13. The method of claim2, wherein the one or more additional agents are a sequestration agent,water and a detergent polymer.
 14. The method of claim 13, wherein thegermicidal composition is for cleaning-in-place.
 15. The method of claim2, wherein the one or more additional agents are a detergent polymer,sequestration agent, a hydrotope, water and a surfactant.
 16. The methodof claim 15, wherein germicidal composition is for premise cleaning. 17.The method of claim 2, wherein the one or more additional agents are asurfactant, water and a mineral acid.
 18. The method of claim 17,wherein germicidal composition is for footbath cleaning.
 19. The methodof claim 2, wherein germicidal composition is for food processing. 20.The method of claim 2, wherein said germicidal composition is configuredto kill bacteria and/or microorganisms associated with hydraulicfracturing.
 21. The method of claim 2, further comprising one or moreprocessors running one or more algorithms, wherein the one or morealgrorithms are a) configured to automatically regulate convertingsodium chloride solution to a solution having chlorine, hypochlorite,hypochlorous acid, and chlorine dioxide, and/or b) configured toautomatically regulate the adding or mixing of the one or morefunctional agents with the concentrate.
 22. A system for on-siteproduction of a germicidal composition, comprising a sodium chloridesolution, an electrolytic cell, one or more additional agents, and atleast one chamber, wherein a) the electrolytic cell is configured to i)receive the sodium chloride solution, ii) remove hydrogen from thesodium chloride solution, and iii) generate a concentrate; b) the atleast one chamber is configured to receive the concentrate generatedwith the electrolytic cell; c) the system is configured to automaticallycombine the one or more additional agents with the concentrate toproduce the germicidal composition, wherein the one or more additionalagents are selected from the group consisting of a detergent polymer, asurfactant, a hydrotrope, a dye, citric acid, an emollient, asequestration agent, an odorant, a mineral acid, a medicinal agent, andwater; and d) the system is closed.
 23. The system of claim 22, whereinthe germicidal composition is removed from the system followingproduction.
 24. The system of claim 23, wherein the germicidalcomposition is sterile.
 25. The system of claim 22, wherein the one ormore additional agents are a detergent polymer, a surfactant, ahydrotope, water and a dye.
 26. The system of claim 25, whereingermicidal composition is for pre-milking udder preparation cleaning.27. The system of claim 22, wherein the one or more additional agentsare a detergent polymer, citric acid, a surfactant, an emollient, asequestration agent, water and a dye.
 28. The system of claim 27,wherein the germicidal composition is for post-milking teat cleaning.29. The system of claim 22, wherein the one or more additional agentsare a surfactant, a sequestration agent, an odorant, water and a dye.30. The system of claim 29, wherein germicidal composition is forlaundry cleaning.
 31. The system of claim 22, wherein the one or moreadditional agents are a sequestration agent, water and a detergentpolymer.
 32. The system of claim 31, wherein the germicidal compositionis for cleaning-in-place.
 33. The system of claim 22, wherein the one ormore additional agents are a detergent polymer, sequestration agent, ahydrotope, water and a surfactant.
 34. The system of claim 33, whereingermicidal composition is for premise cleaning.
 35. The system of claim22, wherein the one or more additional agents are a surfactant, waterand a mineral acid.
 36. The system of claim 35, wherein germicidalcomposition is for footbath cleaning.
 37. The system of claim 22,wherein germicidal composition is for food processing.
 38. The system ofclaim 22, wherein said germicidal composition is configured to killbacteria and/or microorganisms associated with hydraulic fracturing. 39.The system of claim 22, further comprising one or more processorsrunning one or more algorithms, wherein the one or more algrorithms area) configured to automatically regulate converting sodium chloridesolution to a solution having chlorine, hypochlorite, hypochlorous acid,and chlorine dioxide, and/or b) configured to automatically regulate theadding or mixing of the one or more functional agents with theconcentrate.